Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 1,360,824 | 1,309,055 | 1,168,660 | 993,196 | 870,463 |
| Cost of Goods | 611,866 | 617,507 | 553,563 | 487,694 | 472,625 |
| Gross Profit | 748,958 | 691,548 | 615,097 | 505,502 | 397,838 |
| Operating Expenses | 528,007 | 527,172 | 459,627 | 425,446 | 308,716 |
| Operating Income | 221,817 | 164,883 | 156,033 | 80,750 | 89,747 |
| Interest Expense | 9,746 | 13,018 | 14,630 | 17,121 | 16,834 |
| Pre-tax Income | 212,071 | 151,865 | 141,403 | 63,629 | 72,913 |
| Income Tax | 44,392 | 34,307 | 26,002 | 20,254 | -6,556 |
| Net Income Continuous | 167,679 | 117,558 | 115,401 | 43,375 | 79,469 |
| Net Income | $167,679 | $117,558 | $115,401 | $43,375 | $79,469 |
| EPS Basic Total Ops | 3.33 | 2.32 | 2.27 | 0.85 | 1.57 |
| EPS Basic Continuous Ops | 3.33 | 2.32 | 2.27 | 0.85 | 1.57 |
| EPS Diluted Total Ops | 3.31 | 2.29 | 2.24 | 0.84 | 1.55 |
| EPS Diluted Continuous Ops | 3.31 | 2.29 | 2.24 | 0.84 | 1.55 |
| EPS Diluted Before Non-Recurring Items | 4.57 | 3.96 | 3.03 | 2.58 | 2.35 |
| EBITDA(a) | $352,359 | $265,445 | $249,340 | $181,901 | $174,598 |